A newfangled study using risk silhouette and uncertainty approximation for quantification of acyclovir in diverse formulation

Risk assessment and uncertainty approximation are two major and important parameters that need to be adopted for the development of pharmaceutical process to ensure reliable results. Additionally, there is a need to switch from the traditional method validation checklist to provide a high level of a...

Full description

Saved in:
Bibliographic Details
Main Authors: Karan Mittal (Author), Riddhish Patadia (Author), Chintan Vora (Author), Rajashree C. Mashru (Author)
Format: Book
Published: Elsevier, 2015-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3e1a15b95a074c8d857109804cf7f1b0
042 |a dc 
100 1 0 |a Karan Mittal  |e author 
700 1 0 |a Riddhish Patadia  |e author 
700 1 0 |a Chintan Vora  |e author 
700 1 0 |a Rajashree C. Mashru  |e author 
245 0 0 |a A newfangled study using risk silhouette and uncertainty approximation for quantification of acyclovir in diverse formulation 
260 |b Elsevier,   |c 2015-02-01T00:00:00Z. 
500 |a 2095-1779 
500 |a 10.1016/j.jpha.2014.05.005 
520 |a Risk assessment and uncertainty approximation are two major and important parameters that need to be adopted for the development of pharmaceutical process to ensure reliable results. Additionally, there is a need to switch from the traditional method validation checklist to provide a high level of assurance of method reliability to measure quality attribute of a drug product. In the present work, evaluation of risk profile, combined standard uncertainty and expanded uncertainty in the analysis of acyclovir were studied. Uncertainty was calculated using cause-effect approach, and to make it more accurately applicable a method was validated in our laboratory as per the ICH guidelines. While assessing the results of validation, the calibration model was justified by the lack of fit and Levene׳s test. Risk profile represents the future applications of this method. In uncertainty the major contribution is due to sample concentration and mass. This work demonstrates the application of theoretical concepts of calibration model tests, relative bias, risk profile and uncertainty in routine methods used for analysis in pharmaceutical field. Keywords: Acyclovir, Risk profile, Relative bias, Combined standard uncertainty, Expanded uncertainty 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmaceutical Analysis, Vol 5, Iss 1, Pp 58-69 (2015) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S209517791400046X 
787 0 |n https://doaj.org/toc/2095-1779 
856 4 1 |u https://doaj.org/article/3e1a15b95a074c8d857109804cf7f1b0  |z Connect to this object online.